scholarly journals A fatal case of traumatic brain injury with severe coagulopathy due to Rhabdophis tigrinus (yamakagashi) bites: a case report

2021 ◽  
Vol 14 (1) ◽  
Author(s):  
Daisuke Ueno ◽  
Shiino Yasukazu ◽  
Jiro Takahashi ◽  
Satomi Miyamoto ◽  
Takahiro Inoue

Abstract Background Yamakagashi venom is a prothrombin activator, leading to disseminated intravascular coagulation. We report a fatal case of severe coagulopathy from head trauma assumed to be caused by a yamakagashi bite. Case presentation An 80-year-old man fell and developed systemic tonic–clonic convulsions. Head computed tomography revealed brain contusion and acute subdural hematoma. Physical examination revealed two bite marks with persistent bleeding on the right lower leg. The patient stated that he had been bitten by some creature 3 days prior, but the bite was left untreated. Laboratory tests showed fibrinogen levels below the detection limit. Although eighteen units of fresh frozen plasma were administered for coagulopathy, fibrinogen levels did not improve. He died about 18 h after a head injury. Conclusion In this case of a yamakagashi bite with active bleeding due to trauma, early administration of yamakagashi antivenom should be considered to control coagulopathy.

2021 ◽  
Author(s):  
Daisuke Ueno ◽  
Yasukazu Shiino ◽  
Jiro Takahashi ◽  
Satomi Miyamoto ◽  
Takahiro Inoue

Abstract Background Yamakagashi venom is a prothrombin activator, leading to disseminated intravascular coagulation. We report a fatal case of severe coagulopathy from head trauma assumed to be caused by a yamakagashi bite. Case Presentation: An 80-year-old man fell and developed systemic tonic–clonic convulsions. Head computed tomography revealed brain contusion and acute subdural hematoma. Physical examination revealed two bite marks with persistent bleeding on the right lower leg. The patient stated that he had been bitten by some creature 3 days prior, but the bite was left untreated. Laboratory tests showed fibrinogen levels below the detection limit. Even though 18 units of fresh frozen plasma were administered for coagulopathy, fibrinogen levels did not improve. He died approximately 13 hours after admission. Conclusion In this case of a yamakagashi bite with active bleeding due to trauma, early administration of Yamakagashi antivenom should be considered to control coagulopathy.


2018 ◽  
Vol 26 (2) ◽  
pp. 145-147
Author(s):  
Linoel Curado Valsechi ◽  
Lucas Crociati Meguins ◽  
Dionei Freitas De Morais ◽  
Antônio Ronaldo Spott

Introduction: The most common cause of Subarachnoid Hemorrhage (SAH) is trauma and among spontaneous causes the rupture of intracranial aneurysms represents about 75 to 80%. The association between SAH and use of warfarin is a rare condition. Case Report: Female, 50 years, submitted to valvuloplasty surgery on May 2011, and in use of Warfarin since then, presented after one year with a severe headache, describing it as “the worst of her life”, associated to paresis in the left side of the body. Admited to the hospital in GCS 15 with neck stiffness due to hemiparesia in the left side and nasolabial sulcus shift to the right. The head CT (computed tomography) showed SAH Fisher II, without sign of ischemia. The international normalized ratio (INR) was 10. AngioCT did not show aneurism. The patient was taken to ICU, anticoagulant was suspended, the INR was corrected with fresh plasma, and K vitamin and neuroprotective measures were taken. After one month of hospitalization the patient had medical discharge in GCS 15, asymptomatic, with normalized INR and reintroduction of Warfarin. Conclusion: Intracranial hemorrhage associated to the use of oral anticoagulants is the leading cause of death in these patients. However, among them the isolated SAH is a rare event and therefore with few reports in the literature. The INR reversal therapy with the use of prothrombin concentrate, fresh frozen plasma and vitamin K have been adopted in the approach of these patients.


Blood ◽  
2011 ◽  
Vol 118 (21) ◽  
pp. 5278-5278
Author(s):  
Luis Fernando Cortázar-Benítez ◽  
Pablo Vargas Viveros ◽  
Alfredo Aiza Alvarez ◽  
Rafael Hurtado Monroy

Abstract Abstract 5278 HIA due to ozone exposure on patients with glucose 6 phosphate dehydrogenase deficiency (G6PDd) is extremely rare. The purpose of this report is to describe in detail a case of HIA and DVT on a woman without G6PDd, with a successful treatment with fresh frozen plasma (FFP) transfusion and Thrombolysis. The patient is a 36 years old woman, that 3 months before she was diagnosed with multiple sclerosis (MS) because paresthesias in the fingers of her left foot and she received treatment with blood ozone exposure (at unknown dose) in 3 sessions each week for 3 months. The patient attended to our center with severe anemic syndrome during the last 2 weeks and disabling pain of her left leg of 12 hours of evolution. Physical examination showed pale ++++, jaundice ++, functional systolic murmur grade IV, without adenomegaly or splenomegaly, increasing volume, induration, erythema and intense pain from the ankle to the popliteal space of her left leg. The urine was dark. Laboratory data were haemoglobin 5 g/dL, hematocrit 17%, reticulocytes 62%, and platelets 281×109/L. Peripheral blood smear showed esquistocytes +++ and spherocytes ++, suggesting intravascular hemolysis. Total bilirrubin 2.99mg/dL, direct bilirubin 0.57, and LDH 750 U/L. Doppler ultrasound: obstruction of the deep and superficial venous system of tibial, peroneal and left popliteal veins. Four red cells units were transfused and FFP transfusion was started every 6 hours, anticoagulation with enoxaparina sodium (1mg/Kg/day) and thrombolysis with rhTPA 100 mg for 3 hours infusion. The patient successfully improved with increase and maintenance of hemoglobin, decrease of the reticulocytes count and evident clinical improvement of her left leg. She was in-hospital for 8 days at the end of which was achieved ambulation, Doppler showed remission of DVT. The association between exposure to ozone and HIA has not been informed in the absence of G6PD deficiency, and today, little is known of the ideal treatment. Though plasmapheresis is the treatment of choice in a HIA, the presence of DVT and be in a period appropriate for thrombolysis, determined the use of FFP transfusion as the main treatment. The right clinical evolution observed in the treatment of our patient gave her solving clinical problems. Ozone has been widely used for a variety of off-label purposes. In vitro experiments had demonstrated hemolysis with ozone concentration > 30 mcg/mL, therefore this case must represent an important alert for those ozone users, however the mechanism of hemolysis because ozone exposure remains to be elucidated. Disclosures: No relevant conflicts of interest to declare.


2006 ◽  
Vol 120 (2) ◽  
pp. 1-2 ◽  
Author(s):  
Mingyann Lim ◽  
Meena Chaudhari ◽  
Pablo M Devesa ◽  
Angus Waddell ◽  
Deepak Gupta

Airway obstruction secondary to bleeding from warfarin therapy is difficult to manage and uncommon but has been previously described. Previous reports have emphasized the need for reversal of therapy using vitamin K and fresh frozen plasma (FFP). Where a definitive airway has been required, cricothyroidotomy or tracheostomy seem to have been favoured. Several authors have reported failed attempts at endotracheal intubation due to the obstructive effects of a sublingual haematoma. We report here a case which illustrates how endotracheal intubation can be used successfully under the right conditions. It also highlights the superiority of prothrombin complex concentrate over FFP in achieving rapid reversal of abnormal international normalized ratio in the emergency situation.


2020 ◽  
Vol 20 (2) ◽  
pp. 753-757
Author(s):  
Osita U Ezenwosu ◽  
Barth F Chukwu ◽  
Ndubuisi A Uwaezuoke ◽  
Ifeyinwa L Ezenwosu ◽  
Anthony N Ikefuna ◽  
...  

Introduction: Glanzmann’s Thrombasthenia (GT) is a rare autosomal recessive bleeding disorder due to defective platelet membrane glycoprotein GP IIb/IIIa (integrin αIIbβ3). The prevalence is estimated at 1:1,000,000 and it is commonly seen in areas where consanguinity is high. Case Presentation: The authors report a 12 year old Nigerian girl of Igbo ethnic group, born of non-consanguineous parents, who presented with prolonged heavy menstrual bleeding which started at menarche 3 months earlier, weakness and dizziness. She had a past history of recurrent episodes of prolonged epistaxis, gastrointestinal bleeding and gum bleeding during early childhood. On examination, she was severely pale with a haemic murmur and vaginal bleeding. The initial diag- nosis was menorrhagia secondary to bleeding diathesis possibly von Willebrand’s Disease. She was on supportive treatment with fresh whole blood, fresh frozen plasma and platelets until diagnosis of GT was made in the USA. Currently, she is on 3 monthly intramuscular Depo-provera with remarkable improvement. Conclusion: To the best of our knowledge, this is the first documented report of GT in our environment where consan- guinity is rarely practised. Our health facilities require adequate diagnostic and treatment facilities for rare diseases like GT. Keywords: Glanzmann’s thrombasthenia; Menorrhagia; Nigerian girl.


Author(s):  
Salim E. Abboud ◽  
Dean A. Nakamoto ◽  
John R. Haaga

The locally injected blood elements (LIBE) technique represents a useful alternative to systemic administration of blood products to reduce the risk of periprocedural hemorrhage in coagulopathic patients. The LIBE technique results in the creation of a “seroma” of platelets and/or blood products along the expected needle or instrument path to allow a high-quality blood clot to form, and it requires relatively less blood products compared to the more traditional systemic administration technique. Indications for LIBE include and expand on those for systemic administration of blood products to reverse pre-procedural coagulopathy, including contraindications to systemic reversal of pharmacologic anticoagulation, precarious fluid volume status, severe coagulopathy unlikely to normalize with systemic administration of blood products, patient history of adverse reaction to systemic administration of blood products, and limited availability of the desired blood product.


Toxicon ◽  
2019 ◽  
Vol 163 ◽  
pp. 19-22 ◽  
Author(s):  
Harendra Kumara ◽  
Nimal Seneviratne ◽  
Dilini S. Jayaratne ◽  
Sisira Siribaddana ◽  
Geoffrey K. Isbister ◽  
...  

2008 ◽  
Vol 109 (4) ◽  
pp. 664-669 ◽  
Author(s):  
Eric M. Bershad ◽  
Saeid Farhadi ◽  
M. Fareed K. Suri ◽  
Eliahu S. Feen ◽  
Olga H. Hernandez ◽  
...  

Object Acute subdural hematoma (SDH) is one of the most lethal forms of intracranial injury; several risk factors predictive of a worse outcome have been identified. Emerging research suggests that patients with coagulopathy and intracerebral hemorrhage have a worse outcome than patients without coagulopathy but with intracerebral hemorrhage. The authors sought to determine if such a relationship exists for patients with acute SDH. Methods The authors conducted a retrospective analysis of consecutive patients admitted to a neurosciences intensive care unit with acute SDH over a 4-year period (January 1997–December 2001). Demographic data, laboratory values, admission source, prior functional status, medical comorbidities, treatments received, and discharge disposition were recorded, as were scores on the Acute Physiology, Age, and Chronic Health Evaluation III (APACHE III). Coagulopathy was defined as an internal normalized ratio > 1.2 or a prothrombin time ≥12.7 seconds. Univariate and multivariate analyses were performed on 244 patients to determine factors associated with worse short-term outcomes. Results The authors identified 248 patients with acute SDH admitted to the neurointensive care unit during the study period, of which 244 had complete data. Most were male (61%), and the mean age of the study population was 71.3 ± 15 years (range 20–95 years). Fifty-three patients (22%) had coagulopathy. The median APACHE III score was 43 (range 11–119). Twenty-nine patients (12%) died in the hospital. Independent predictors of inhospital death included APACHE III score (odds ratio [OR] 4.4, 95% confidence interval [CI] 1.4–13.4, p = 0.011) and coagulopathy (OR 2.7, 95% CI 1.1–7.1, p = 0.037). Surgical evacuation of acute SDH was associated with reduced inhospital deaths (OR 0.2, 95% CI 0.1–0.6, p = 0.003). Conclusions Coagulopathy is independently associated with inhospital death in patients with acute SDH. Time to treatment to correct coagulopathy using fresh frozen plasma and/or vitamin K was prolonged.


2013 ◽  
Vol 1 (2) ◽  
pp. 8-10 ◽  
Author(s):  
Kate Khair ◽  
Poornima Kumar ◽  
Mary Mathias ◽  
Jemma Efford ◽  
Ri Liesner

Abstract Introduction: Severe factor X deficiency is a rare serious bleeding disorder historically treated with fresh frozen plasma (FFP) and more recently with prothrombin complex concentrate (PCC) which contains activated factors II, VII, IX and X. The infusion volume of PCC is smaller than FFP, but there is a risk of thromboembolic complications given the presence of activated forms of vitamin K-dependent factor concentrates when treating an isolated coagulation factor deficiency. Methods: We describe the case of a nine-year-old girl of consanguineous origin with co-existent congenital merosin deficient muscular dystrophy and severe factor X deficiency treated with twice-weekly PCC prophylaxis via an indwelling central venous access device (CVAD). Infusion occlusion of her fifth CVAD occurred 24-months post-insertion; thrombus within the right subclavian and brachiocephalic veins was seen on radiological imaging. She started peripheral treatment with BPL Factor X concentrate as infusion volumes were smaller and given her immobility further thrombotic risk was predicted to be reduced. A sixth CVAD was inserted seven months later and BPL Factor X prophylaxis was continued. Results:BPL Factor X concentrate was effective in maintaining trough levels of 13IU/ml 72-hours post-dose, with no intercurrent bleeding episodes or further problems in terms of occlusion of her portacath. Further radiological screening has not been undertaken. Conclusion: BPL Factor X has been shown to be a safe and effective alternative to PCC for treatment of severe factor X deficiency in this case.


2018 ◽  
Vol 26 (2) ◽  
pp. 288-295
Author(s):  
Pavel N. Myshencev ◽  
Sergey E. Katorkin ◽  
Leonid A. Lichman

The importance of treatment of patients with lymphedema of lower limbs arises from difficulties in their medical and social rehabilitation. At the expressed stages of the disease resection surgical operations are indicated which present complicated interventions. In the work clinical observation of a 33 yearold female patient with IV stage of primary lymphedema of the right lower limb is presented. In the course of conservative treatment after a complex examination including volumetry, ultrasound, computed tomography, the patient was made dermalipofascioectomy using method of shave therapy. The operation of modified dermalipofascioectomy of the shin was performed by Karavanov II method under spinal anesthesia with use of mono and bipolar coagulation. At the stage of elimination of fibrotically changed tissue dermatome Acculan 3Ti (GA 670) was used with controlled ranges of thickness within 0.21.2 mm and width within 878 mm. Intraoperative loss of blood and lymph was 800 ml and was compensated for with crystalloid, colloid solutions and fresh frozen plasma in the volume of 600 ml. Active drainage of the region of the postoperative wound was conducted by Redon method within 1012 days. Postoperative period ran without complications, with improvement of the patient’s condition. Clinical observation showed a positive role of application of shave therapy apparatus at the main stage of resection operations.


Sign in / Sign up

Export Citation Format

Share Document